Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
From the reviews:
“The concept of active surveillance (AS) was developed by Klotz, with the aim of limiting the risk of overtreatment in patients with low-risk cancers, while providing timely radical treatment for those requiring it. Currently, this concept is supported by an increasing number of urologists. ... This excellent overview dedicated to AS fills a lack in the literature. ... this textbook can be recommended to all physicians involved in prostate cancer management.” (European Urology Today, Vol. 25 (2), March-May, 2013)
“This book summarizes the current worldwide experience with active surveillance for prostate cancer. ... this book is appropriate for primary care physicians, surgeons, medical oncologists, radiation oncologists, pathologists, radiologists, psychiatrists, and psychologists. Furthermore, it would be valuable to the general audience and patients as it clearly describes the role and implications of active surveillance in the treatment of prostate cancer. ... I strongly recommend this book to any clinician whose practice involves the treatment of patients with prostate cancer in any capacity.” (Sanjay Kasturi, Doody’s Book Reviews, October, 2012)
Chapter 1. The Problem of Cancer Overdiagnosis and Overtreatment
by Laurence Klotz
Chapter 2. Patient Selection for Active Surveillance
by John Eifler and H. Ballentine Carter
Chapter 3. Predicting High Risk Disease Using Tissue Biomarkers
by Michael J. Donovan and Carlos Cordon-Cardo
Chapter 4. Predicting High Risk Disease Using Serum and DNA Biomarkers
by Danny Vesprini and Robert Nam
Chapter 5. Triggers for Intervention in Men on Surveillance
by S.Y. Jackie Sham and Chris Parker
Chapter 6. The Role of MRI in Active Surveillance
by Caroline M. Moore, Clare Allen, Mark Emberton
Chapter 7. Active Surveillance: The European Experience
by Meelan Bul, Monique J. Roobol and Chris H. Bangma
Chapter 8. Active Surveillance: The Canadian Experience
by Laurence Klotz
Chapter 9. Psychosocial Aspects of Active Surveillance
by Meredith Wallace Kazer, Dwanna M. Ward-Boahen, David M. Latini, Donald E. Bailey, Jr.
Chapter 10. Statistical Considerations for Patient Selection and Triggers for Intervention in Active Surveillance
by Andrew J. Vickers
Chapter 11. Interpreting PSA Kinetics using GLMM Technique
by Liying Zhang and Laurence Klotz
Chapter 12. The Potential Benefits of Diet and Physical Activity among Active Surveillance Patients with Low-Burden Prostate Cancer
by Stacey A. Kenfield, J. Kellogg Parsons, June M. Chan
Chapter 13. The Role of 5α-Reductase Inhibitors (5-ARIs) in Expectant Management of Low Risk Prostate Cancer
by David Margel and Neil Fleshner
Chapter 14. Urologists’ Opinion on Active Surveillance: United States vs. the Netherlands
by Lionne D.F. Venderbos, Chris H. Bangma, Ida J. Korfage
Chapter 15. Clinical ‘Pearls’ in Managing Patients on Surveillance
by Laurence Klotz
Chapter 16. Active Surveillance, Focal Therapy and the Future
by Mark Emberton
Chapter 17. The Economics of Active Surveillance for Prostate Cancer
by Marc A. Dall’Era and Christopher P. Evans
Chapter 18. The Future of Active Surveillance
by Sima P. Porten, Jared M. Whitson, Peter R. Carroll
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
Spese di spedizione:
EUR 3,70
In U.S.A.
Descrizione libro Hardcover. Condizione: New. Brand New Book. Codice articolo b19410